FP1039/GSK3052230 with chemotherapy in patients with fibroblast growth factor (FGF) pathway deregulated squamous NSCLC or MPM Meeting Abstract


Authors: Garrido, P.; Delgado, I.; Felip, E.; Domine, M.; Paik, P.; Trigo, J.; Schellens, J.; Gadgeel, S.; Kindler, H. L.; Lara, P. Jr; Orlov, S.; Vansteenkiste, J.; Levchenko, E.; Lassen, U.; Viteri, S.; Hambleton, J.; Baker-Neblett, K.; Yan, L.; Wang, C.; Sedoti, D.; Kirby, G.; Mitrica, I.; Botbyl, J.; Morgensztern, D.
Abstract Title: FP1039/GSK3052230 with chemotherapy in patients with fibroblast growth factor (FGF) pathway deregulated squamous NSCLC or MPM
Meeting Title: 16th World Conference on Lung Cancer (WCLC)
Journal Title: Journal of Thoracic Oncology
Volume: 10
Issue: 9 Suppl. 2
Meeting Dates: 2015 Sep 6-9
Meeting Location: Denver, CO
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S403
Language: English
ACCESSION: WOS:000370365101427
PROVIDER: wos
PUBMED: 26710300
DOI: 10.1016/S1556-0864(16)30011-9
Notes: Meeting Abstract: MINI38.06 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik